A recent cross-sectional study illustrated that BDNF is higher in late-onset AD and lower in early-onset AD than controls (Wang et al., 2023), suggesting that expression of BDNF in plasma is altered at the clinical stage of AD. Here, BDNF is linked to Alzheimer disease.